Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Studying cancer from the inside out: What the epigenetic code can tell doctors about disease

Reporter: Aviva Lev-Ari, PhD, RN

Receiving a cancer diagnosis can feel like losing control of everything. In the wake of such a diagnosis, patients, family and friends often yearn for more information. Is it aggressive? What treatments are offered? Will those treatments work? Will it spread? Sometimes doctors can offer answers, but in other cases they are elusive. Without information, the patient may decide to treat a benign tumor with harsh drugs or risky surgery or may take a wait-and-see approach with an aggressive tumor-neither of which are ideal.

Sourced through Scoop.it from: www.genome.gov

See on Scoop.it – Cardiovascular Disease: PHARMACO-THERAPY